// App-Quantinova.ai

643 : Implementation of a risk-based low-molecular weight heparin protocol for venous thromboembolism prevention in postpartum women

Researchers

Presenter

  • Elizabeth H. Robison

Principal Investigators

  • Kent Heyborne

  • Amanda A. Allshouse

  • Carolyn Valdez

  • Torri D. Metz

Medical Centers

  • University of Colorado Denver School of Medicine, Aurora, CO

  • Denver VA Medical Center, Denver, CO

  • Colorado School of Public Health, Aurora, CO

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Central Nervous System (CNS)

  • Blood/haematological Diseases

  • Pulmonary/Respiratory Diseases

  • Cardiovascular (CVS)

Disease

  • Venous thrombosis

  • Hematoma

Biomarkers

  • N/A

Drug/Treatment

  • Heparin

Outcome

  • N/A

Study Design

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved